Not applicableStudy completedNCT05522283What this trial is testingStool and Serum CMV-PCR in Diagnosing CMV ColitisWho this might be right forCMV Colitis Mahidol University 137
Post-approval studies (Phase 4)Study completedNCT01243489What this trial is testingCompliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND OptimisationWho this might be right forChronic Myelogenous Leukemia (CML) Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Testing effectiveness (Phase 2)Study completedNCT02353858What this trial is testingPreoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal CancerWho this might be right forRectal CancerLocally Advanced Rectal CancerHyperthermia+3 more University Hospital Tuebingen 78
Testing effectiveness (Phase 2)Looking for participantsNCT05268289What this trial is testingStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VWho this might be right forLupus Nephritis Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)UnknownNCT05596890What this trial is testingPatient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer PatientsWho this might be right forEsophageal Squamous Cell CarcinomaPatient-reported OutcomesImmunotherapy Guangdong Provincial People's Hospital 50
Not applicableLooking for participantsNCT07289282What this trial is testingCirculating microRNAs and Response to Neoadjuvant Chemotherapy in Breast CancerWho this might be right forBreast CancerNeoadjuvant TherapyPathological Response+2 more Atlas University 80
Large-scale testing (Phase 3)Temporarily pausedNCT05503108What this trial is testingFasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast CancerWho this might be right forFasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more Leiden University Medical Center 10
Not applicableActive Not RecruitingNCT07509632What this trial is testingPredicting Pathological Complete Response in Rectal Cancer Using Machine LearningWho this might be right forRectal CancersPathological Complete ResponseNeoadjuvant Chemoradiotherapy+1 more Peking University People's Hospital 320
Testing effectiveness (Phase 2)Study completedNCT00466726What this trial is testingVaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous LeukemiaWho this might be right forLeukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Testing effectiveness (Phase 2)Study completedNCT02789254What this trial is testingFLYSYN in MRD Positive AMLWho this might be right forAcute Myeloid Leukemia Synimmune GmbH 31
Testing effectiveness (Phase 2)Looking for participantsNCT07593976What this trial is testingEvaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast CancerWho this might be right forBreast Cancer Centre Henri Becquerel 42
Not applicableStudy completedNCT05495308What this trial is testing"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".Who this might be right forRectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more Hospital San Carlos, Madrid 4
Not applicableLooking for participantsNCT07066189What this trial is testingLifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBCWho this might be right forTriple Negative Breast Cancer Yale University 160
Large-scale testing (Phase 3)Looking for participantsNCT06393374What this trial is testingSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Who this might be right forTriple-Negative Breast Cancer Merck Sharp & Dohme LLC 1,530
Testing effectiveness (Phase 2)Study completedNCT01914900What this trial is testingPreoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell CancerWho this might be right forLocally Advanced Resectable Oral Cavity Squamous Cell Cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Large-scale testing (Phase 3)Study completedNCT02003209What this trial is testingDocetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerWho this might be right forHER2-Positive Breast CarcinomaHormone Receptor-Positive Breast CarcinomaStage IB Breast Cancer AJCC v7+5 more National Cancer Institute (NCI) 315
Not applicableLooking for participantsNCT04743102What this trial is testingMulti-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal CancerWho this might be right forRectal CancerNeoadjuvant TherapyComplete Remission+1 more Beijing Chao Yang Hospital 260
Large-scale testing (Phase 3)Study completedNCT06775652What this trial is testingNeoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Yongtao Han 254
Not applicableStudy completedNCT01433926What this trial is testingCharacteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 YearsWho this might be right forHER-2 Positive Breast Cancer Asociación para el Progreso de la Oncología en Málaga 114
Early research (Phase 1)Study completedNCT01933906What this trial is testingAddition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular ResponseWho this might be right forChronic Phase Chronic Myeloid Leukemia Arbeitsgemeinschaft medikamentoese Tumortherapie 12